c-Fms-IN-12

• UNSPSC Description:

  c-Fms-IN-12 (Compound 4g) is an FMS kinase inhibitor. c-Fms-IN-12 can also inhibits c-KIT. c-Fms-IN-12 is a potential broad-spectrum anticancer agent against multiple cancer types. c-Fms-IN-12 induces A549 cell apoptosis[1].

• Target Antigen:

  Apoptosis; c-Fms; c-Kit

• Type:

  Reference compound

• Related Pathways:

  Apoptosis;Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/c-fms-in-12-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NC1=CN=C(NC2=CC=C(N3CCOCC3)C=C2)N=C1OC4=CC=CC(OC)=C4)NC5=CC(OC)=CC(OC)=C5

• Molecular Weight:

  572.61

• References & Citations:

  [1]Farag AK, et al. Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches. Bioorg Chem. 2020 Oct;103:104121.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2145102-33-4